The Scientific and Clinical Potential of 89Zr Crefmirlimab Berdoxam (CD8 ImmunoPET™) to Visualize and Quantify Tumor-Infiltrating CD8+ T Cells

The Scientific and Clinical Potential of 89Zr Crefmirlimab Berdoxam (CD8 ImmunoPET™) to Visualize and Quantify Tumor-Infiltrating CD8+ T Cells presented at WMIC 2023